Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 FDA Probes MicroMed Cardiovascular - Medical Product Outsourcing

What are you searching for?

Sign in

FDA Probes MicroMed Cardiovascular

Company says 4-year-old cancier patient died from chemotherapy complications.

By: Editor

NULL

The U.S. Food and Drug Administration (FDA) is looking into whether MicroMed Cardiovascular, which received a warning letter from the agency in December, should have reported a death that could allegedly be related to the DeBakey VAD Child Device.

“Significant deviations include failure to report to the FDA no later than 30 calendar days after the day that your firm received or otherwise became aware of information, from any source, that reasonably suggests that your marketed device may have caused or contributed to a death or serious injury,” the letter says.

A MicroMed official said the device did not cause the 4-year-old cancer patient’s death and that the child eventually died from chemotherapy complications, according to published reports.

MicroMed received FDA approval in 2004 for device, which is implanted in the patient’s chest.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Add Medical Product Outsourcing as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters

Topics